Vivatech 2023

France

Mablink Bioscience

Health
Mablink aims to transform the immunotherapy of cancers with its next generation Antibody-Drug Conjugates (ADC), leveraging PSARlink™, its innovative proprietary hydrophilic drug-linker platform. Mablink is developing its own pipeline of ADCs.
Wed
Thu
Fri
Sat

More info

LOOKING FOR

None


Hosted By

Media gallery

URL DE LA  VIDEO DE PRESENTATION

DATES / SEE ALL / MENUS / SESSIONS

GTM